$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

$uavs Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224012100 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.894M	$2.922M	$13.74M
YoY Change	-4.01%	-34.68%	-28.03%
Cost Of Revenue	$1.940M	$1.683M	$8.278M
YoY Change	-6.66%	-25.32%	-23.89%
Gross Profit	$1.954M	$1.239M	$5.463M
YoY Change	-1.22%	-44.19%	-33.52%
Gross Profit Margin	50.18%	42.4%	39.76%
Selling, General & Admin	$3.218M	$3.987M	$17.33M
YoY Change	-29.39%	-17.32%	-23.61%
% of Gross Profit	164.66%	321.76%	317.29%
Research & Development	$1.130M	$1.203M	$5.500M
YoY Change	-28.57%	-37.59%	-32.21%
% of Gross Profit	57.83%	97.12%	100.67%
Depreciation & Amortization	$102.1K	$781.8K	$257.1K
YoY Change	1.37%	-25.66%	-42.35%
% of Gross Profit	5.22%	63.1%	4.71%
Operating Expenses	$4.348M	$5.190M	$44.61M
YoY Change	-29.18%	-23.58%	-38.46%
Operating Profit	-$2.394M	-$3.951M	-$39.15M
YoY Change	-42.47%	-13.57%	-39.09%
Interest Expense	$3.489M	$46.19K	$326.9K
YoY Change	-1242.01%	-253.92%	446.87%
% of Operating Profit
Other Income/Expense, Net	-$3.922M	-$21.16K	-$3.272M
YoY Change	794.57%	-94.46%	-154.32%
Pretax Income	-$6.316M	-$24.51M	-$42.42M
YoY Change	37.31%	-47.54%	-27.18%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$6.316M	-$24.51M	-$42.42M
YoY Change	37.31%	-47.54%	-27.18%
Net Earnings / Revenue	-162.17%	-838.81%	-308.71%
Basic Earnings Per Share	-$0.77		-$8.04
Diluted Earnings Per Share	-$0.77	-$3.91	-$8.04
COMMON SHARES
Basic Shares Outstanding	10.89M shares	117.9M shares	5.280M shares
Diluted Shares Outstanding	8.234M shares		5.280M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$822.9K	$819.0K	$819.0K
YoY Change	-71.1%	-81.17%	-81.17%
Cash & Equivalents	$822.9K	$819.0K
Short-Term Investments
Other Short-Term Assets	$720.7K	$548.6K	$548.6K
YoY Change	-14.05%	-46.72%	-46.72%
Inventory	$6.438M	$6.937M	$6.937M
Prepaid Expenses
Receivables	$1.351M	$2.058M	$2.058M
Other Receivables	$0.00	$185.0K	$185.0K
Total Short-Term Assets	$9.333M	$10.55M	$10.55M
YoY Change	-30.17%	-27.08%	-27.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$666.2K	$799.9K	$4.325M
YoY Change	-4.85%	1.1%	-8.82%
Goodwill	$7.403M	$7.403M
YoY Change	-68.06%	-68.06%
Intangibles	$2.457M	$2.615M
YoY Change	-77.37%	-77.27%
Long-Term Investments
YoY Change
Other Assets	$249.8K	$265.6K	$265.6K
YoY Change	-17.53%	-8.76%	-8.76%
Total Long-Term Assets	$13.89M	$14.61M	$14.61M
YoY Change	-64.23%	-63.22%	-63.22%
TOTAL ASSETS
Total Short-Term Assets	$9.333M	$10.55M	$10.55M
Total Long-Term Assets	$13.89M	$14.61M	$14.61M
Total Assets	$23.22M	$25.16M	$25.16M
YoY Change	-55.5%	-53.57%	-53.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.648M	$3.063M	$3.063M
YoY Change	80.45%	65.99%	65.99%
Accrued Expenses	$1.691M	$1.944M	$2.824M
YoY Change	410.76%	448.87%	22.33%
Deferred Revenue	$349.5K	$226.3K
YoY Change	-37.02%	-54.41%
Short-Term Debt	$678.6K	$4.505M	$4.505M
YoY Change	-27.32%	1467.44%	1467.44%
Long-Term Debt Due	$310.0K	$391.6K	$391.6K
YoY Change	-31.28%	-12.3%	-12.3%
Total Short-Term Liabilities	$11.30M	$11.03M	$11.03M
YoY Change	115.9%	104.89%	104.89%
LONG-TERM LIABILITIES
Long-Term Debt	$355.2K	$489.0K	$489.0K
YoY Change	-12.58%	9.45%	-78.81%
Other Long-Term Liabilities	$2.514M	$2.938M	$2.938M
YoY Change	-16.15%	-10.1%	-10.1%
Total Long-Term Liabilities	$355.2K	$489.0K	$3.427M
YoY Change	-12.58%	9.45%	-38.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.30M	$11.03M	$11.03M
Total Long-Term Liabilities	$355.2K	$489.0K	$3.427M
Total Liabilities	$14.17M	$14.46M	$14.46M
YoY Change	41.37%	31.91%	31.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$177.1M	-$165.6M
YoY Change	52.18%	48.43%
Common Stock	$10.89K	$140.5K
YoY Change	-88.0%	58.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.053M	$10.70M	$10.70M
YoY Change
Total Liabilities & Shareholders Equity	$23.22M	$25.16M	$25.16M
YoY Change	-55.5%	-53.57%	-53.57%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$6.316M	-$24.51M	-$42.42M
YoY Change	37.31%	-47.54%	-27.18%
Depreciation, Depletion And Amortization	$102.1K	$781.8K	$257.1K
YoY Change	1.37%	-25.66%	-42.35%
Cash From Operating Activities	-$1.553M	-$2.126M	-$10.96M
YoY Change	-63.32%	-55.38%	-45.51%
INVESTING ACTIVITIES
Capital Expenditures	$22.40K	$115.4K	$215.4K
YoY Change	319.67%	81.98%	-31.36%
Acquisitions
YoY Change
Other Investing Activities	-$20.68K	-$91.61K	-$561.6K
YoY Change	-91.69%	-60.79%	-93.02%
Cash From Investing Activities	-$43.08K	-$217.0K	-$777.0K
YoY Change	-83.05%	-26.95%	-90.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.967M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.642M	1.821M	$8.551M
YoY Change	-45.27%	-44.58%	-52.13%
NET CHANGE
Cash From Operating Activities	-$1.553M	-2.126M	-$10.96M
Cash From Investing Activities	-$43.08K	-217.0K	-$777.0K
Cash From Financing Activities	$1.642M	1.821M	$8.551M
Net Change In Cash	$3.897K	-522.8K	-$3.531M
YoY Change	-100.26%	-70.59%	-65.52%
FREE CASH FLOW
Cash From Operating Activities	-$1.553M	-$2.126M	-$10.96M
Capital Expenditures	$22.40K	$115.4K	$215.4K
Free Cash Flow	-$1.575M	-$2.242M	-$11.17M
YoY Change	-62.84%	-53.58%	-45.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	UAVS	Long Term Portion Of Promissory Note LongTermPortionOfPromissoryNote		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	UAVS	Payment Of Acquisitionrelated Liabilities PaymentOfAcquisitionrelatedLiabilities		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	UAVS	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition		usd
CY2022	UAVS	Rightofuse Asset And Liability RightofuseAssetAndLiability		usd
CY2023	UAVS	Issuance Of Restricted Common Stock IssuanceOfRestrictedCommonStock		usd
CY2023	UAVS	Settlement Of Common Stock From Contingent Liability Related To Measure SettlementOfCommonStockFromContingentLiabilityRelatedToMeasure		usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10956377	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2022Q4	UAVS	Impairment Of Intangible Asset ImpairmentOfIntangibleAsset		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	UAVS	Change In Deferred Tax Assets Valuation Allowance ChangeInDeferredTaxAssetsValuationAllowance		usd
CY2022	UAVS	Change In Deferred Tax Assets Valuation Allowance ChangeInDeferredTaxAssetsValuationAllowance		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	25134429	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10891427	shares
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	100
CY2023	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2023	dei	Auditor Location AuditorLocation	Orlando, Florida
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	819024	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4349837	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2057546	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6936980	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	548561	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1029548	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10547111	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14463272	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	799892	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3525406	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2615281	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11507653	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7402644	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	265567	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	291066	usd
CY2023Q4	us-gaap	Assets Assets	25155901	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3062794	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1845135	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1944352	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1680706	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4504500	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	287381	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	226316	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	496390	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	901925	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q4	UAVS	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	391545	usd
CY2022Q4	UAVS	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	446456	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11031432	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5384181	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2721743	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	489037	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	446813	usd
CY2023Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	216133	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	106163	usd
CY2022Q4	UAVS	Long Term Portion Of Promissory Note LongTermPortionOfPromissoryNote	1861539	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14458345	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10960399	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	140520163	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	140520163	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88466613	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88466613	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	140521	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	88467	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	176033817	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154679363	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165583091	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111553444	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	106303	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10083	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10697556	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25155901	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54184874	usd
CY2023	us-gaap	Revenues Revenues	13741398	usd
CY2022	us-gaap	Revenues Revenues	19094425	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	8278158	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10876308	usd
CY2023	us-gaap	Gross Profit GrossProfit	5463240	usd
CY2022	us-gaap	Gross Profit GrossProfit	8218117	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17757708	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	21755360	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	41687871	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	44613352	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	72494954	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-39150112	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-64276837	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-948564	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-59785	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1933368	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6463101	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25960	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-389693	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-354242	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3271625	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6023114	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42421737	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58253723	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-42421737	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58253723	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.97
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.97
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5279595	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5279595	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4168521	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4168521	shares
CY2023	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	244323	usd
CY2022	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-135439	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-340543	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	54762	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42325517	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58173046	usd
CY2023	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-339631	usd
CY2022	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-172596	usd
CY2023	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	-11607910	usd
CY2022	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	-2245377	usd
CY2023	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-54273058	usd
CY2022	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-60591019	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	76576913	usd
CY2022	UAVS	Stock Issued During Period Value Settlement Of Heldback Shares From Contingent Liability Related To Measure Acquisition StockIssuedDuringPeriodValueSettlementOfHeldbackSharesFromContingentLiabilityRelatedToMeasureAcquisition	2812500	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	9920000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-172596	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4583341	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
CY2022	UAVS	Stock Issued During Period Value Relative Fair Value Of Warrants Issued With Promissory Note StockIssuedDuringPeriodValueRelativeFairValueOfWarrantsIssuedWithPromissoryNote	1182349	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74350	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3420664	usd
CY2022	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	135439	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-54762	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58253723	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4675000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-339631	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3967400	usd
CY2023	UAVS	Stock Issued During Period Value Conversion Of Warrants Issued With Promissory Note And Incremental Value Modification StockIssuedDuringPeriodValueConversionOfWarrantsIssuedWithPromissoryNoteAndIncrementalValueModification	190500	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1305329	usd
CY2023	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	-244323	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	340543	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-42421737	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10697556	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10697556	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-42421737	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58253723	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15776767	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	41687871	usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	5899307	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	79287	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1305329	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3420664	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3811770	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3938860	usd
CY2023	UAVS	Defined Benefit Plan Obligation And Other DefinedBenefitPlanObligationAndOther	93692	usd
CY2022	UAVS	Defined Benefit Plan Obligation And Other DefinedBenefitPlanObligationAndOther	-215797	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25960	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	612712	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	46270	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1933368	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6463101	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-223457	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-637156	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-53178	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2605028	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-543703	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-230688	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1105947	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-681556	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	44499	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-716960	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-280685	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-472604	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	263029	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-340886	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10956377	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19762186	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	215357	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	313769	usd
CY2022	UAVS	Payment Of Acquisitionrelated Liabilities PaymentOfAcquisitionrelatedLiabilities	6610900	usd
CY2023	UAVS	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	357724	usd
CY2022	UAVS	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	817029	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	203889	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	618061	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-776970	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8359759	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3967400	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4583341	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	4675000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	9920000	usd
CY2023	UAVS	Repayments On Covid Loans RepaymentsOnCovidLoans	91856	usd
CY2022	UAVS	Repayments On Covid Loans RepaymentsOnCovidLoans	345484	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3285000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74350	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8550544	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17517207	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-348010	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364009	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3530813	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10240729	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4349837	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14590566	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	819024	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4349837	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	7590	usd
CY2022	UAVS	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition	3000000	usd
CY2023	UAVS	Rightofuse Asset And Liability RightofuseAssetAndLiability	212756	usd
CY2023	UAVS	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	27805	usd
CY2022	UAVS	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	6805	usd
CY2023	UAVS	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	339631	usd
CY2022	UAVS	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	172596	usd
CY2023	UAVS	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant	11607910	usd
CY2022	UAVS	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant	2245377	usd
CY2022	UAVS	Issuance Of Restricted Common Stock IssuanceOfRestrictedCommonStock	483	usd
CY2022	UAVS	Settlement Of Common Stock From Contingent Liability Related To Measure SettlementOfCommonStockFromContingentLiabilityRelatedToMeasure	2812500	usd
CY2023	us-gaap	Profit Loss ProfitLoss	42400000	usd
CY2023Q4	UAVS	Working Capital Deficit WorkingCapitalDeficit	500000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zWWcFYKdI222" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zCqeKjIo4UMj">Use of Estimates </span></i>- The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the reserve for obsolete inventory, valuation of stock issued for services and stock options, and valuation of intangible assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2100000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2900000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	200000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	500000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1000000.0	usd
CY2023	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.0049	pure
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	158689	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16800	usd
CY2023Q4	UAVS	Finite Lived Intangibles Assets Net FiniteLivedIntangiblesAssetsNet	582148	usd
CY2022Q4	UAVS	Finite Lived Intangible Assets FiniteLivedIntangibleAssets	721795	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	5899307	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
CY2023	UAVS	Shipping Costs ShippingCosts	260000	usd
CY2022	UAVS	Shipping Costs ShippingCosts	340000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	100000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	350000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5500000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8100000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zFZKTp5tval2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_z7eoQRGpZD9e">Customer Concentrations</span></i> - As of December 31, 2023, there was one significant customer comprising over <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zs2cbE7iujTi" title="Concentration risk, percentage">10</span>% of our accounts receivable balance. As of December 31, 2022, we did not have any customers that exceeded <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zOFTEwOpfCAe" title="Concentration risk, percentage">10</span>% of our accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	UAVS	Income Tax Rate Reconciliation Description IncomeTaxRateReconciliationDescription	The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted.
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1806239	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	614400	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2216235	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2229840	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	158689	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16800	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2057546	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4648966	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5288206	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	903217	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1106056	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	7358422	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	7008662	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	421442	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	322815	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6936980	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q4	us-gaap	Supplies Supplies	12738	usd
CY2022Q4	us-gaap	Supplies Supplies	281484	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	182510	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	184429	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	51497	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	234691	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	166210	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	167794	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	63209	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	99558	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	72397	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	61592	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	548561	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1029548	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1792384	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1494896	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	992492	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	703741	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	799892	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023	us-gaap	Depreciation Depreciation	257092	usd
CY2022	us-gaap	Depreciation Depreciation	445929	usd
CY2023Q4	UAVS	Accrued Purchases And Customer Deposits AccruedPurchasesAndCustomerDeposits	290126	usd
CY2022Q4	UAVS	Accrued Purchases And Customer Deposits AccruedPurchasesAndCustomerDeposits	102319	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	278794	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	774916	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	303217	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	288807	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	512227	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	172596	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	211086	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	262737	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	326945	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	21957	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	79331	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1944352	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1680706	usd
CY2021Q4	UAVS	Good Faith Acquisition Ofconsideration GoodFaithAcquisitionOfconsideration	15000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11507653	usd
CY2023	UAVS	Intangible Assets Excluding Goodwill Additions IntangibleAssetsExcludingGoodwillAdditions	561613	usd
CY2023	UAVS	Amortization Of Intangible Assets Excluding Goodwill AmortizationOfIntangibleAssetsExcludingGoodwill	3554678	usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	5899307	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2615281	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y5M1D
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16511732	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7997144	usd
CY2023Q4	UAVS	Impairment Of Intangible Asset ImpairmentOfIntangibleAsset	5899307	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2615281	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13565494	usd
CY2022	UAVS	Intangible Assets Excluding Goodwill Additions IntangibleAssetsExcludingGoodwillAdditions	1435090	usd
CY2022	UAVS	Amortization Of Intangible Assets Excluding Goodwill AmortizationOfIntangibleAssetsExcludingGoodwill	3492931	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11507653	usd
CY2022Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P4Y9M
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15950121	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4442468	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11507653	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P3Y5M1D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P4Y9M
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3554678	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3492931	usd
CY2023	UAVS	Adjustment For Amortization Of Development Costs AdjustmentForAmortizationOfDevelopmentCosts	720635	usd
CY2022	UAVS	Adjustment For Amortization Of Development Costs AdjustmentForAmortizationOfDevelopmentCosts	480393	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	716907	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	541175	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	373838	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	349923	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	213802	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	4504500	usd
CY2023Q4	UAVS	Percentage Of Aggregate Of The Offered Securities PercentageOfAggregateOfTheOfferedSecurities	0.50	pure
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	419636	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2615281	usd
CY2020Q4	us-gaap	Goodwill Goodwill	3108000	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	74117203	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12357921	usd
CY2021Q4	us-gaap	Goodwill Goodwill	64867282	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	41687871	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15776767	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7402644	usd
CY2023	UAVS	Covid Loan Disclosuretext Block CovidLoanDisclosuretextBlock	<p id="xdx_804_ecustom--CovidLoanDisclosuretextBlock_zrmWWg2lwmId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_827_zXV3ATEaQ3P4">COVID Loan</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the senseFly Acquisition, the Company assumed the obligations for two COVID Loans originally made by the SBA to senseFly S.A. on July 27, 2020 (“senseFly COVID Loans”). As of senseFly Acquisition Date, the fair value of the COVID Loan was $<span id="xdx_90D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--SenseflyMember_zNX4yq5n1TR6" title="Fair value of the covid loan">1,440,046</span> (“senseFly COVID Loans”). For the twelve months ended December 31, 2023 and 2022, senseFly S.A. made the required payments on the senseFly COVID Loans, including principal and accrued interest, aggregating approximately $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zVIbRCYx9Ric" title="Payment of principal and interest">91,856</span> and $<span id="xdx_907_eus-gaap--RepaymentsOfDebt_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_z7KOpntGZsIa" title="Payment of principal and interest">345,484</span>, respectively. As of December 31, 2023, the Company’s outstanding obligations under the senseFly COVID Loans are $<span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zvV6yBBxQJi6" title="Outstanding obligations under the covid loans">880,582</span>. On August 25, 2023, the Company modified one (1) of its existing agreements to extend the repayment period of the COVID Loan from a maturity date of December 2023 to June 2025. The other COVID loan remains unchanged.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGEAGLE AERIAL SYSTEMS INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – COVID Loan- Continued</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z4itoc3SB7Jk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, scheduled principal payments due under the senseFly COVID Loans are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zKu4bmICGPy5" style="display: none">Schedule of Maturity of SenseFly Covid Loans</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_49C_20231231__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zUWlKGxVk8Q1"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year Ending December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_maLTDzGkt_z8A8CvESLpx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">391,545</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_maLTDzGkt_zNbfaaA1jHga" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">195,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_maLTDzGkt_zSoybOpMMkNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">97,887</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_maLTDzGkt_zwl3p4AN8Eo2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">195,769</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebt_iI_mtLTDzGkt_zKCKaLHPGoEk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">880,582</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zzIBgsGJmAt6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3500000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5000000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.44
CY2022Q4	UAVS	Debt Instrument Original Issue Discount Percent DebtInstrumentOriginalIssueDiscountPercent	0.04	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2022Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3285000	usd
CY2022Q4	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	140000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	75000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1847200	usd
CY2023	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	1182349	usd
CY2023	UAVS	Debt Instrument Discount Including Fair Value Of Warrants DebtInstrumentDiscountIncludingFairValueOfWarrants	1397350	usd
CY2022Q2	us-gaap	Investments In And Advances To Affiliates At Fair Value Gross Additions InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions	3300000	usd
CY2023	UAVS	Gains Losses On Extinguishment Of Debt Net GainsLossesOnExtinguishmentOfDebtNet	2571133	usd
CY2023Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	409500	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	4504500	usd
CY2023Q4	UAVS	Net Proceeds Percentage NetProceedsPercentage	0.50	pure
CY2023Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2000000	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	412188	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	326945	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	326945	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	4504500	usd
CY2022Q4	UAVS	Description Of Down Round Or Anti Dilution Trigger Event DescriptionOfDownRoundOrAntiDilutionTriggerEvent	a down round or anti-dilution trigger event occurred resulting in the conversion rate on the Series F and the exercise price of the Series F Warrants issued with the Series F adjusting down to $0.44 from $0.62 and $0.96, respectively (the “December Down Round Trigger”).
CY2023	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	2245377	usd
CY2023Q1	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	255976	usd
CY2023Q2	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	4654918	usd
CY2023Q4	UAVS	Aggregate Purchase Price AggregatePurchasePrice	1850000	usd
CY2023	us-gaap	Dividends Dividends	339631	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2022	us-gaap	Dividends Dividends	172596	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	839247	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	697361	usd
CY2023Q4	UAVS	Lieu Payment LieuPayment	55133	usd
CY2023Q3	UAVS	Lieu Payment LieuPayment	15000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2561231	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.18
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2022Q4	UAVS	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue	31124	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	325000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.32
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.15
CY2023	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y7D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	380999	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.83
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.99
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2505232	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.00
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.08
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M26D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2294	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2309199	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.13
CY2023Q4	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue	1.16
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y3M7D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2294	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2541667	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.88
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.57
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1244029	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	512065	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.66
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.32
CY2022	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y7D
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	185000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.40
CY2022	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0.29
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	307501	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.47
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.46
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2561231	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.18
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	31124	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2046309	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.37
CY2022Q4	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue	1.30
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y21D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	31124	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.32
CY2022Q4	us-gaap	Share Price SharePrice	0.66
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6364	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6949	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0422	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0347	pure
CY2023	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	259031	usd
CY2023	UAVS	Defined Benefit Plan Interest Costs DefinedBenefitPlanInterestCosts	66136	usd
CY2023	us-gaap	Defined Benefit Plan Divestitures Plan Assets DefinedBenefitPlanDivestituresPlanAssets	133373	usd
CY2023	UAVS	Defined Benefit Plan Amortization Of Prior Service Costs Credit DefinedBenefitPlanAmortizationOfPriorServiceCostsCredit	-2205	usd
CY2023	UAVS	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncome	38579	usd
CY2023	us-gaap	Pension Expense PensionExpense	228168	usd
CY2022Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	3299621	usd
CY2023	UAVS	Service Cost ServiceCost	259031	usd
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	66136	usd
CY2023	us-gaap	Contribution Of Property ContributionOfProperty	207225	usd
CY2023	UAVS	Actuarial Gains And Losses ActuarialGainsAndLosses	87078	usd
CY2023	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-84874	usd
CY2023	UAVS	Plan Amendments Related To Statutory Changes PlanAmendmentsRelatedToStatutoryChanges	-1225712	usd
CY2023	us-gaap	Defined Benefit Plan Plan Assets Foreign Currency Translation Gain Loss DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss	269346	usd
CY2023Q4	UAVS	Pbo Beginning Of Period PboBeginningOfPeriod	2877851	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	98669	usd
CY2023	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation	2779182	usd
CY2022Q4	UAVS	Fair Value Of Plan Assets Beginning Of Period FairValueOfPlanAssetsBeginningOfPeriod	3296404	usd
CY2023	UAVS	Defined Benefit Plan Expected Return On Plan Asset DefinedBenefitPlanExpectedReturnOnPlanAsset	133373	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-287690	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	302019	usd
CY2023	us-gaap	Origination Of Loans To Employee Stock Ownership Plans OriginationOfLoansToEmployeeStockOwnershipPlans	207225	usd
CY2023	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	84874	usd
CY2023	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1160679	usd
CY2023	UAVS	Foreign Currency Exchange Rate Change ForeignCurrencyExchangeRateChange	255940	usd
CY2023Q4	UAVS	Fair Value Of Plan Assets Beginning Of Period FairValueOfPlanAssetsBeginningOfPeriod	2661718	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	2661718	usd
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	3296403	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	2661718	usd
CY2023Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	2877851	usd
CY2023Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-216133	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	10572	usd
CY2023	UAVS	Defined Benefit Plan Amortization Of Gain Loss DefinedBenefitPlanAmortizationOfGainLoss	-178544	usd
CY2023Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-167972	usd
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0210	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.0125	pure
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0210	pure
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0125	pure
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0385	pure
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate	0.0210	pure
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	432265	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	387629	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	347691	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	310103	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	277213	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	1045423	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	2800324	usd
CY2023	us-gaap	Multiemployer Plan Pension Significant Plan Contribution MultiemployerPlanPensionSignificantPlanContribution	77240	usd
CY2022	us-gaap	Multiemployer Plan Pension Significant Plan Contribution MultiemployerPlanPensionSignificantPlanContribution	149543	usd
CY2023Q1	us-gaap	Additional Liability Long Duration Insurance Gross Premium Income AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome	3000000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3525406	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	901925	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2721743	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1039685	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1287143	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1094321	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1100394	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	878571	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	792947	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	198237	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4064470	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	440802	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3623668	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	901925	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2721743	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.0779	pure
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y10M24D
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2023	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	1054847	usd
CY2022	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	1614468	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	1387303	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	3155867	usd
CY2022	UAVS	Related Party Cost RelatedPartyCost	18371	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17794764	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11170665	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17794764	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11170665	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6624099	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2350212	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8931931	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12233282	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-152856	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0036	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-193910	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0033	pure
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	3313121	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	8590427	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.1475	pure
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	41757	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0010	pure
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	301687	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0051	pure
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1762090	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0414	pure
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-57579	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0009	pure
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-12606	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0003	pure
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	172056	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0030	pure
CY2023	UAVS	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	196163	usd
CY2023	UAVS	Income Tax Reconciliation Return To Provision Adjustment Rate IncomeTaxReconciliationReturnToProvisionAdjustmentRate	-0.0046	pure
CY2022	UAVS	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	369793	usd
CY2022	UAVS	Income Tax Reconciliation Return To Provision Adjustment Rate IncomeTaxReconciliationReturnToProvisionAdjustmentRate	-0.0063	pure
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	684343	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0161	pure
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	700596	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0120	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6624099	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1557	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2350212	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0403	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	17806	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1109854	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1001945	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	16406	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	754211	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16889316	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10396086	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	150351	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	150351	usd
CY2023Q4	UAVS	Deferred Tax Assets Right Of Use Liability DeferredTaxAssetsRightOfUseLiability	147861	usd
CY2022Q4	UAVS	Deferred Tax Assets Right Of Use Liability DeferredTaxAssetsRightOfUseLiability	-127473	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	18331594	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12175120	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17794764	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11170665	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1183	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	100019	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	410463	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	1036649	usd
CY2023Q4	UAVS	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	125184	usd
CY2022Q4	UAVS	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-132213	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	536830	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1004455	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-5750	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5750	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5750	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5750	usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-5750	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses	5750	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42421737	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58253723	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7402644	usd
CY2023Q4	us-gaap	Assets Assets	25155901	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023	us-gaap	Revenues Revenues	13741398	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	8278158	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-39150112	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3271625	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-42421737	usd
CY2022	us-gaap	Revenues Revenues	19094425	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10876308	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-64276837	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6023114	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-58253723	usd
CY2023	us-gaap	Revenues Revenues	13741398	usd
CY2022	us-gaap	Revenues Revenues	19094425	usd

Files In Submission

Name	View Source	Status
0001493152-24-012100-index-headers.html	Edgar Link	pending
0001493152-24-012100-index.html	Edgar Link	pending
0001493152-24-012100.txt	Edgar Link	pending
0001493152-24-012100-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
ex97-2.htm	Edgar Link	pending
ex97-2_001.jpg	Edgar Link	pending
ex97-2_002.jpg	Edgar Link	pending
ex97-2_003.jpg	Edgar Link	pending
ex97-2_004.jpg	Edgar Link	pending
ex97-2_005.jpg	Edgar Link	pending
ex97-3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uavs-20231231.xsd	Edgar Link	pending
uavs-20231231_def.xml	Edgar Link	unprocessable
uavs-20231231_lab.xml	Edgar Link	unprocessable
uavs-20231231_pre.xml	Edgar Link	unprocessable
uavs-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

2024 Q1 Form 10-K Financial Statement

#000149315224012100 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS AgEagle Aerial Systems Inc. Stock $uavs

2024 Q1 Form 10-K Financial Statement

#000149315224012100 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs